Patent · US Active

Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivate

US8460712B2 · kind B2 · utility

2Cited by

0References

20Claims

0Family size

Assignee

UCB PHARMA S.A. · BE

Inventors

Domenico Fanara · Wanze, BE
Frederic Eeckman · Brussels, BE
Monique Berwaer · Montigny-le-Tilleul, BE

Key dates

Filing date	Nov 17, 2009
Grant date	Jun 11, 2013
Priority date	—
Expiry date	Jan 31, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a pharmaceutical composition comprising Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation made of granules containing the active ingredient in their inner core.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.